Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Pfizer for InfoPages here.
Pfizer - Latest News [Page 1]
Got Plans? COVID Doesn’t Care: Kiwis Reminded To Check Their Risk Ahead Of Holiday Season
Wednesday, 18 September 2024, 12:12 pm | Pfizer
Pfizer New Zealand launched a new COVID-19 awareness campaign today to remind Kiwis, ahead of summer, to check if they are at increased risk of getting severe COVID-19. More >>
COVID-19 Summer Checklist: How Kiwis Can Embrace Their Holiday Season – Survey
Tuesday, 22 November 2022, 10:25 am | Pfizer
New research released by Pfizer today reveals that only 14% of New Zealanders feel that their life is back to normal following the COVID-19 pandemic. With the nation planning its summer in the midst of rising case numbers, Kiwis are being encouraged ... More >>
Half Of Kiwis Eligible For Potentially Lifesaving COVID-19 Antiviral Treatments Know Little About Them – Survey
Thursday, 13 October 2022, 9:06 am | Pfizer
New research released today reveals that despite one million New Zealanders being eligible to treat their COVID-19 infection with antiviral medication*, over half (54%) know very little about the treatments. The online study of more than 1,500 ... More >>
Pfizer To Provide Additional 40,000 PAXLOVID Treatment Courses In New Zealand To Help Combat COVID-19
Tuesday, 13 September 2022, 5:35 am | Pfizer
Pfizer confirms it will supply an additional 40,000 PAXLOVID® (nirmatrelvir tablets and ritonavir tablets) treatment courses to the New Zealand Government, bringing the total to 100,000 PAXLOVID treatment courses in New Zealand for 2022. PAXLOVID ... More >>
First Shipment Of PAXLOVID, Pfizer’s Novel COVID-19 Oral Treatment Arrives In New Zealand
Thursday, 31 March 2022, 6:49 am | Pfizer
• PAXLOVIDTM (nirmatrelvir [PF-07321332] is the first oral treatment of its kind; it includes nirmatrelvir, a 3CL (or main) protease inhibitor specifically designed to combat SARS-CoV-2. tablets and ritonavir tablets) • Medsafe gave provisional ... More >>
Pfizer To Provide New Zealand With 60,000 Treatment Courses Of Investigational Oral Antiviral Candidate
Monday, 6 December 2021, 3:52 pm | Pfizer
Pfizer New Zealand announced today an agreement with the New Zealand Government to supply 60,000 treatment courses of its investigational COVID-19 oral antiviral candidate, PF-07321332; ritonavir, subject to regulatory approval from Medsafe. If approved ... More >>
Pfizer NZ Statement on Supply
Friday, 10 September 2021, 1:51 pm | Pfizer
Pfizer is committed to equitable access that will give all people access to a vaccine. Pfizer NZ entered into an initial agreement with the Government to supply 1.5 million doses of the Pfizer-BioNTech COVID-19 vaccine on 22 December 2020 and entered into ... More >>
IBRANCE® (palbociclib) Patient Support Website Launched
Wednesday, 21 April 2021, 2:42 pm | Pfizer
Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz . This new website has been designed to provide support for women with hormone-receptor ... More >>
Pfizer NZ Is Honoured Is To Be Chosen As The New Zealand Government’s Primary Vaccine Provider
Tuesday, 9 March 2021, 5:47 am | Pfizer
Pfizer has entered into an agreement with the New Zealand government to provide 8.5 million additional doses of its mRNA vaccine COMIRNATY. Pfizer is committed to supply 10 million doses of the vaccine to New Zealand over the course of 2021. Pfizer ... More >>
IBRANCE® (palbociclib) To Be Funded From 1 April
Thursday, 5 March 2020, 8:16 am | Pfizer
IBRANCE® (palbociclib) to be funded from 1 April for HR positive/HER2 negative (HR+/HER2–) advanced or metastatic breast cancer Pfizer New Zealand today welcomed the decision by PHARMAC to fund IBRANCE (palbociclib) from 1 April 2020 for women ... More >>
IBRANCE® (palbociclib) to be funded
Wednesday, 15 January 2020, 11:14 am | Pfizer
Pfizer New Zealand today welcomed the provisional decision by PHARMAC to fund IBRANCE (palbociclib) for women with hormone-receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2–) advanced or metastatic breast cancer ... More >>
Significant New Breast Cancer Treatment Available in NZ
Monday, 4 September 2017, 8:47 am | Pfizer
An entirely new form of anti-cancer therapy that works to apply the brakes to cancer cell division and growth can now be prescribed for New Zealand women with a common and incurable type of breast cancer. More >>
Educational Lung Cancer Poster - Lung Cancer Awareness Month
Monday, 3 November 2014, 11:34 am | Pfizer
Pfizer New Zealand will launch an educational poster about lung cancer, to hang in the foyer of Christchurch Hospital, to help raise awareness of lung cancer and its symptoms as part of Lung Cancer Awareness Month in November. More >>
Pfizer launches a stronger Smokefree Workplace Policy
Tuesday, 29 May 2012, 10:03 am | Pfizer
Pfizer launches a stronger Smokefree Workplace Policy and new quit smoking resources for Kiwis on World Smokefree Day More >>
Innovative new product will help New Zealand lamb
Monday, 30 August 2010, 12:56 pm | Pfizer
Pfizer Animal Health launched an innovative new drench to New Zealand sheep farmers, which could help save our country’s valuable lamb industry millions of dollars a year in lost productivity. More >>
Smokers Offered One of Best-Ever Odds of Quitting
Thursday, 2 August 2007, 3:36 pm | Pfizer
Kiwi smokers throughout New Zealand now have access to a ground-breaking new product called CHAMPIX® (varenicline) which offers them one of their best-ever odds for breaking their addiction to nicotine. More >>
Pfizer Launches New Cancer Treatment In NZ
Friday, 4 May 2007, 10:24 am | Pfizer
The availability in New Zealand of Pfizer’s new cancer treatment Sutent (sunitinib malate), for two hard-to-treat cancers has been welcomed by leading oncologists in both Australia and New Zealand, said Pfizer Australia and New Zealand Senior Medical ... More >>
Pfizer Launches New Cancer Treatment in NZ
Thursday, 3 May 2007, 4:56 pm | Pfizer
The availability in New Zealand of Pfizer’s new cancer treatment Sutent (sunitinib malate), for two hard-to-treat cancers has been welcomed by leading oncologists in both Australia and New Zealand, said Pfizer Australia and New Zealand Senior Medical ... More >>
Survey: Communication Gap Between Doctors, Smokers
Monday, 26 March 2007, 2:55 pm | Pfizer
Most doctors and smokers agree that quitting smoking is the best way to improve health Smokers say they get advice on how to quit smoking half as often as doctors say they provide it More >>
Pharmaceutical Research And Development In NZ
Tuesday, 30 May 2006, 11:52 am | Pfizer
Pharmaceutical companies are abandoning research and development in New Zealand due to a lack of government support, potentially costing the country $100 million in lost investment, according to a report released today. More >>
